Anthony M. Nicasio

发表

Length of Stay and Hospital Costs Associated with a Pharmacodynamic‐Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator‐Associated Pneumonia

D. Nicolau, J. Kuti, K. Eagye, 2010, Pharmacotherapy.

Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit?

T. Lodise, Anthony M. Nicasio, J. Butterfield, 2014, Diagnostic microbiology and infectious disease.

Optimization of meropenem dosage in the critically ill population based on renal function

R. Ariano, D. Nicolau, J. Crandon, 2011, Intensive Care Medicine.

Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.

D. Nicolau, M. Palter, J. Kuti, 2010, Journal of critical care.

Pharmacotherapy of Complicated Urinary Tract and Intra-abdominal Infections with Doripenem

D. Nicolau, J. Kuti, Anthony M. Nicasio, 2009 .

An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity.

M. Neely, D. Nicolau, M. Scheetz, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival

M. Neely, D. Nicolau, Jiajun Liu, 2015, Antimicrobial Agents and Chemotherapy.

Bronchopulmonary Disposition of Micafungin in Healthy Adult Volunteers

D. Nicolau, J. Kuti, P. Tessier, 2008, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2016, Antimicrobial Agents and Chemotherapy.

Characterization of the Pharmacokinetics-Pharmacodynamics of Tazobactam in 1 Combination with Piperacillin in an In Vitro Infection Model 2

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2016 .

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2013, Antimicrobial Agents and Chemotherapy.

In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a KPC Carbapenemase

D. Nicolau, D. Wiskirchen, J. Kuti, 2011, Antimicrobial Agents and Chemotherapy.

In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates

D. Nicolau, J. Crandon, Anthony M. Nicasio, 2009, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia

R. Ariano, D. Nicolau, Aryun Kim, 2009, Antimicrobial Agents and Chemotherapy.

The Current State of Multidrug‐Resistant Gram‐Negative Bacilli in North America

D. Nicolau, Joseph L. Kuti, David P. Nicolau, 2008, Pharmacotherapy.

Evaluation of Once-Daily Vancomycin against Methicillin-Resistant Staphylococcus aureus in a Hollow-Fiber Infection Model

G. Drusano, J. Bulitta, A. Louie, 2011, Antimicrobial Agents and Chemotherapy.

Treatment of Serratia marcescens Meningitis with Prolonged Infusion of Meropenem

D. Nicolau, R. Quintiliani, J. Kuti, 2007, The Annals of pharmacotherapy.

Influence of automated screening and confirmation of extended-spectrum beta-lactamase-producing members of the Enterobacteriaceae on prescribing of antibiotics.

D. Nicolau, J. Kuti, J. Aslanzadeh, 2008, Journal of medical microbiology.